A REGENERATIVE PLATFORM FOR HAIR GROWTH
"THE DOGMA WAS THAT YOU WERE BORN WITH THE TOTAL NUMBER OF HAIR FOLLICLES THAT YOU WERE EVER GOING TO HAVE. THEIR LOSS WAS CONSIDERED PERMANENT. NOW, WE KNOW IT'S NOT."
- Dr. George Cotsarelis, Chair of the Department of Dermatology at the University of Pennsylvania & Follica Scientific Co-founder
Follica is a biotechnology company developing a platform technology for hair loss based on breakthrough research in regenerative biology. We’ve teamed up with leading dermatologists with expertise in hair loss and epithelial stem cell biology to develop a new system aimed at not just improving existing hair growth, but also growing new hair.
Currently-approved treatments work with only the hair you already have...either transplanting existing hair, or reviving shrunken hair follicles which cause hair to thin and stop growing with age. Our technology is based on a proprietary approach intended to create an "embryonic window" in adult skin, allowing new follicles and new hair to form from epithelial stem cells.
Following skin disruption, cells that migrate to help healing are forced to make a decision: Should I make epidermis, or should I make a hair? There is a window of opportunity in which we can potentially push them to choose the latter, and we believe there are multiple biological pathways to target to enhance this outcome. This regenerative effect is called hair follicle neogenesis.
FOLLICA HAS AN EXCLUSIVE, WORLDWIDE LICENSE FROM THE UNIVERSITY OF PENNSYLVANIA TO DEVELOP AND COMMERCIALIZE THIS POTENTIALLY BREAKTHROUGH TECHNOLOGY, CLINICALLY DEMONSTRATED TO STIMULATE THE GENESIS AND DEVELOPMENT OF NEW FOLLICLES IN ADULT HUMANS.
A REVOLUTIONARY DEVICE CONCEPT
We are developing a system for hair loss, informed by scientific rigor, clinical research, and user experience design. A procedure would be performed in-office by a licensed medical professional, using Follica’s proprietary device to disrupt the skin and create new hair follicles.
CAUTION: Investigational device and new drug. Limited by United States law to investigational use.
Led by a team with expertise spanning medical devices, drugs, and software to shape the future of hair loss.
Collaborating with leading clinicians and researchers with expertise in clinical development and hair growth.